ARCHIVES

House, Senate Must Resolve Major Differences In Authorization Bills

This article is from The Cancer Letter archive.

Vol. 06 No. 36 | September 12, 1980

Download PDF Visit The Full Archive

Related Articles

FDA will return memento given to McClellan by NCI Director Andrew von Eschenbach.

February 6, 2004

Duke Physician, BM, Patients, Lobby For Reimbursement

October 22, 1993

Judge Invalidates Bristol-Myers’ Claims For The Administration Of Taxol.

March 3, 2000

NCI Staff Finishes Center Program Study, Submits Recommendations

February 25, 1977

CALGB Says Results In Adjuvant Setting Too Preliminary; Follow Up Planned In Three Years

April 16, 1999

NCI Plans SBIR “Bridge” Award To Commercialize Technology.

April 11, 2008